TELA Bio, Inc. (TELA) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 56.08M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 59.74M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $56.08M | (m) | (m) | $59.74M | (m) |
| 2026-03-31 | (m) | (m) | (m) | $55.87M | (m) | (m) | $69.89M | (m) |
| 2025-12-31 | (m) | (m) | (m) | $55.65M | (m) | (m) | $81.42M | (m) |
| 2025-09-30 | (m) | (m) | (m) | $41.49M | (m) | (m) | $61.59M | (m) |
| 2025-06-30 | (m) | (m) | $3.33M | $38.05M | (m) | (m) | $67.54M | (m) |
| 2025-03-31 | (m) | (m) | (m) | $41.27M | (m) | (m) | $77.25M | (m) |
| 2024-12-31 | (m) | (m) | (m) | $41.12M | (m) | (m) | $86.57M | (m) |
| 2024-09-30 | (m) | (m) | (m) | $40.97M | (m) | (m) | $53.02M | (m) |
| 2024-06-30 | (m) | (m) | (m) | $40.82M | (m) | (m) | $60.20M | (m) |
| 2024-03-31 | (m) | (m) | (m) | $40.66M | (m) | (m) | $71.84M | (m) |
| 2023-12-31 | (m) | (m) | (m) | $40.52M | (m) | (m) | $78.05M | (m) |
| 2023-09-30 | (m) | (m) | (m) | $40.36M | (m) | (m) | $87.32M | (m) |
| 2023-06-30 | (m) | (m) | (m) | $40.21M | (m) | (m) | $94.39M | (m) |
| 2023-03-31 | (m) | (m) | (m) | $40.06M | (m) | (m) | $58.79M | (m) |
| 2022-12-31 | (m) | (m) | (m) | $39.92M | (m) | (m) | $67.86M | (m) |
| 2022-09-30 | (m) | (m) | (m) | $39.77M | (m) | (m) | $79.56M | (m) |
| 2022-06-30 | (m) | (m) | (m) | $39.62M | (m) | (m) | $51.33M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |